The EPFO accordingly, has been authorized to issue the Certificate of Coverage to the employees posted to the countries having signed Agreement with the Government of India.

Sadly, a perception has surfaced whereby employers are not inclined to employ women as they would then be required to sponsor them for a 26-week long paid maternity leave.

Oil and Gas industry differs from other industries as to how it is valued financially; relying on factors which are subject to changes frequently.

Recently, there was a huge debate going-on both at the state and center level regarding online sales of the medicine.

A Biosimilar Bevacizumab for Treating Several Types of Cancer

The Union Cabinet, chaired by the Prime Minister of India, has given approval to accede to the Protocol under World Health Organization (WHO) Framework Convention on Tobacco Control ...

On January 19, 2018, the CDSCO has published clarification regarding issuance of NOC for issuing Form 29 License used to manufacture drugs for the purposes of examination, test or analysis of biological products (Vaccines 86 r-DNA products).

In February 2019, the Government of India introduced first draft regulatory guidelines for evaluation of nanopharmaceutical products for therapeutic use in the country.

On July 10, 2019, Indian Pharmacopoeia Commission declared that the Government of Ghana has given recognition to the Indian pharmacopoeia after continuous efforts of Central government in achieving the recognition

It will also enable rigorous punishment to the offenders if the drug is found illegally stocked or distributed.

Union Health Ministry has proposed to amend Rule 26 of D&C Rules to make it mandatory the import license holder to maintain a reference sample.

Under Trade-Related Aspects of Intellectual Property Rights (TRIPS)' there was no access to medicines for underdeveloped countries for treating serious health issues.

This segment of the newsletter shares recent information related to regulatory reforms from Healthcare and Pharmaceutical sectors in India.

This segment of the newsletter shares recent information related to regulatory reforms from Healthcare and Pharmaceutical sectors in India.

. Out of this, an amount of INR 5.56 crore has been recovered and demand notices amounting to INR 89.31 crore are under litigation.

On April 22, 2019, a MOU was signed between the Ministry of AYUSH and CSIR for cooperation in research, education and interdisciplinary sciences that integrate/co-opt traditional systems of medicine and modern science.

Globally, pneumonia causes more than a quarter of deaths in children under the age of five – that is nearly one million young lives lost per year.

AMR is a major global challenge and is getting the attention of all relevant stakeholders. Factors such as inappropriate and irrational use of antimicrobial agents among others have led to the increase in AMR.

On March 19, 2019 the U.S. Food and Drug Administration approved Zulresso (brexanolone) intravenous (IV) formulation for the treatment of postpartum depression (PPD) in adult women.

This is the first and only treatment for nraxSpA approved by USFDA.